Sunshine Heart stops trial enrollment after patient deaths

Shares of Sunshine Heart plunge after the company reveals a halt in U.S. clinical trial enrollment for its C-Pulse heart failure device.

Food & Drug Administration (FDA), Sunshine Heart Inc.

News Well, Clinical Trials, Cardiac Assist Devices, Regulatory/Compliance

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1H6HB8R